![Cancers | Free Full-Text | Mutant p53L194F Harboring Luminal-A Breast Cancer Cells Are Refractory to Apoptosis and Cell Cycle Arrest in Response to MortaparibPlus, a Multimodal Small Molecule Inhibitor Cancers | Free Full-Text | Mutant p53L194F Harboring Luminal-A Breast Cancer Cells Are Refractory to Apoptosis and Cell Cycle Arrest in Response to MortaparibPlus, a Multimodal Small Molecule Inhibitor](https://www.mdpi.com/cancers/cancers-13-03043/article_deploy/html/images/cancers-13-03043-g001.png)
Cancers | Free Full-Text | Mutant p53L194F Harboring Luminal-A Breast Cancer Cells Are Refractory to Apoptosis and Cell Cycle Arrest in Response to MortaparibPlus, a Multimodal Small Molecule Inhibitor
![Isolation and characterization of a new basal-like luminal progenitor in human breast tissue | Stem Cell Research & Therapy | Full Text Isolation and characterization of a new basal-like luminal progenitor in human breast tissue | Stem Cell Research & Therapy | Full Text](https://media.springernature.com/m685/springer-static/image/art%3A10.1186%2Fs13287-019-1361-3/MediaObjects/13287_2019_1361_Fig4_HTML.png)
Isolation and characterization of a new basal-like luminal progenitor in human breast tissue | Stem Cell Research & Therapy | Full Text
![p53 Expression in Luminal Breast Cancer Correlates With TP53 Mutation and Primary Endocrine Resistance - Modern Pathology p53 Expression in Luminal Breast Cancer Correlates With TP53 Mutation and Primary Endocrine Resistance - Modern Pathology](https://www.modernpathology.org/cms/attachment/47fdbfad-daca-49ca-b2a6-9b9b69300dfe/gr1.jpg)
p53 Expression in Luminal Breast Cancer Correlates With TP53 Mutation and Primary Endocrine Resistance - Modern Pathology
![Luminal Agency Limited(Company Register Number: 2410594) - 新成立/注册及已更改名称的公司名单| 香港公司名單數據集/ Hong Kong Companies Datasets 💿 Luminal Agency Limited(Company Register Number: 2410594) - 新成立/注册及已更改名称的公司名单| 香港公司名單數據集/ Hong Kong Companies Datasets 💿](https://hkg.databasesets.com/en/business-card-sample/2410594.png)
Luminal Agency Limited(Company Register Number: 2410594) - 新成立/注册及已更改名称的公司名单| 香港公司名單數據集/ Hong Kong Companies Datasets 💿
![A CD146 FACS Protocol Enriches for Luminal Keratin 14/19 Double Positive Human Breast Progenitors | Scientific Reports A CD146 FACS Protocol Enriches for Luminal Keratin 14/19 Double Positive Human Breast Progenitors | Scientific Reports](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41598-019-50903-9/MediaObjects/41598_2019_50903_Fig1_HTML.png)
A CD146 FACS Protocol Enriches for Luminal Keratin 14/19 Double Positive Human Breast Progenitors | Scientific Reports
![Ductal keratin 15+ luminal progenitors in normal breast exhibit a basal-like breast cancer transcriptomic signature | npj Breast Cancer Ductal keratin 15+ luminal progenitors in normal breast exhibit a basal-like breast cancer transcriptomic signature | npj Breast Cancer](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41523-022-00444-8/MediaObjects/41523_2022_444_Fig4_HTML.png)
Ductal keratin 15+ luminal progenitors in normal breast exhibit a basal-like breast cancer transcriptomic signature | npj Breast Cancer
![Influence of luminal and basal subtype in prognosis of high-grade non muscle invasive urothelial carcinoma - ScienceDirect Influence of luminal and basal subtype in prognosis of high-grade non muscle invasive urothelial carcinoma - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1092913422001836-gr3.jpg)
Influence of luminal and basal subtype in prognosis of high-grade non muscle invasive urothelial carcinoma - ScienceDirect
![L to R Hyper Luminal Creative Director Rob Madden, CEO Stuart Martin, Chairman Sean Tracey - Holyrood PR L to R Hyper Luminal Creative Director Rob Madden, CEO Stuart Martin, Chairman Sean Tracey - Holyrood PR](https://www.holyroodpr.co.uk/wp-content/uploads/2022/04/L-to-R-Hyper-Luminal-Creative-Director-Rob-Madden-CEO-Stuart-Martin-Chairman-Sean-Tracey.jpg)
L to R Hyper Luminal Creative Director Rob Madden, CEO Stuart Martin, Chairman Sean Tracey - Holyrood PR
![High luminal pH of GABAergic SVs. (A) Fluorescence images of syp-mOr... | Download Scientific Diagram High luminal pH of GABAergic SVs. (A) Fluorescence images of syp-mOr... | Download Scientific Diagram](https://www.researchgate.net/publication/307920268/figure/fig1/AS:573803689852928@1513816868018/High-luminal-pH-of-GABAergic-SVs-A-Fluorescence-images-of-syp-mOr-and-Venus-syp-mOr.png)
High luminal pH of GABAergic SVs. (A) Fluorescence images of syp-mOr... | Download Scientific Diagram
Takeda Announces Topline Results of Phase 3 ADMIRE-CD II Trial of Alofisel® (darvadstrocel) in Complex Crohn's Perianal Fistulas
![Identification of a Low-Risk Luminal A Breast Cancer Cohort That May Not Benefit From Breast Radiotherapy | Journal of Clinical Oncology Identification of a Low-Risk Luminal A Breast Cancer Cohort That May Not Benefit From Breast Radiotherapy | Journal of Clinical Oncology](https://ascopubs.org/cms/10.1200/JCO.2014.57.7999/asset/images/zlj9991052520002.jpeg)
Identification of a Low-Risk Luminal A Breast Cancer Cohort That May Not Benefit From Breast Radiotherapy | Journal of Clinical Oncology
![Identification of a Low-Risk Luminal A Breast Cancer Cohort That May Not Benefit From Breast Radiotherapy | Journal of Clinical Oncology Identification of a Low-Risk Luminal A Breast Cancer Cohort That May Not Benefit From Breast Radiotherapy | Journal of Clinical Oncology](https://ascopubs.org/na101/home/literatum/publisher/asco/journals/content/jco/2015/jco.2015.61.33.issue-18/jco.2015.61.33.issue-18/20160927-01/jco.2015.61.33.issue-18.largecover.png)